G. Veyrac

Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?

C. Joyau, G. Veyrac, Veronique Dixneuf et al. · PubMed · 2013 · 90 citations

Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study

A. Soria, C. Bernier, G. Veyrac et al. · Journal of the American Academy of Dermatology · 2019 · 79 citations · Full text

Retrospective Study, Drug Hypersensitivity, Systemic Symptoms +6

Lopinavir pharmacokinetics in COVID-19 patients

Matthieu Grégoire, Paul Le Turnier, Benjamin Gaborit et al. · Journal of Antimicrobial Chemotherapy · 2020 · 62 citations · Full text

A statement on cefazolin immediate hypersensitivity: data from a large database, and focus on the cross‐reactivities

A. Pipet, G. Veyrac, F. Wessel et al. · Clinical & Experimental Allergy · 2011 · 43 citations

Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009–2013 French PharmacoVigilance assessment

Guillaume Moulis, Haleh Bagheri, L. Sailler et al. · European Journal of Internal Medicine · 2014 · 30 citations

Drug Safety, Drug Interactions, Pharmacoepidemiology +10